Literature DB >> 4391660

Conditions for the formation, partial purification and assay of an inhibitor of adenosine 3',5'-monophosphate.

F Murad, T W Rall, M Vaughan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4391660     DOI： 10.1016/0304-4165(69)90392-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  6 in total

1.  Biosynthesis of the endogenous cyclic adenosine monophosphate (AMP) antagonist, prostaglandylinositol cyclic phosphate (cyclic PIP), from prostaglandin E and activated inositol polyphosphate in rat liver plasma membranes.

Authors:  H K Wasner; M Lessmann; M Conrad; H Amini; E Psarakis; A Mir-Mohammad-Sadegh
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

2.  [Cyclic nucleotides as intracellular transmitter substances in hormone actions].

Authors:  G Schultz
Journal:  Klin Wochenschr       Date:  1971-10-01

3.  A simple, sensitive protein-binding assay for guanosine 3':5'-monophosphate.

Authors:  F Murad; V Manganiello; M Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

4.  Adenosine 3':5'-monophosphate content and actions in the division cycle of synchronized HeLa cells.

Authors:  C E Zeilig; R A Johnson; E W Sutherland; D L Friedman
Journal:  J Cell Biol       Date:  1976-11       Impact factor: 10.539

5.  Effect of thyrocalcitonin on adenosine 3':5'-cyclic phosphate formation by rat kidney and bone.

Authors:  F Murad; H B Brewer; M Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1970-02       Impact factor: 11.205

6.  Lasting biological effects of early environmental influences. VII. Metabolism of adenosine in mice exposed to early environmental stress.

Authors:  C J Lee; R Dubos
Journal:  J Exp Med       Date:  1972-02-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.